Companies

EXELIXIS, INC. (EXEL) SEC filings

CIK 0000939767 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 01/01

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)2.3 B1.6 B
Net income (USD)111.8 M321.0 M
Diluted EPS (USD/shares)2.780.56

Latest filings

FiledFormDescriptionPeriod
2026-09-118-K8-K items 8.012026-09-10
2026-08-318-K8-K items 8.012026-08-31
2026-08-14SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-124FORM 42026-08-10
2026-08-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-10144144
2026-08-05S-8S-8
2026-08-0510-Q10-Q2026-07-03
2026-08-058-K8-K items 2.02,9.012026-08-05
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-01144144
2026-06-01144144
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-294FORM 42026-05-27
2026-05-29442026-05-27
2026-05-298-K8-K items 5.02,5.07,9.012026-05-26
2026-05-284FORM 42026-05-26

Forms on file (last 1,000): 4 639, 8-K 94, 144 86, SC 13G/A 27, 10-Q 26, DEFA14A 18, S-8 POS 17, CT ORDER 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=EXEL (0.002 USD), /gw/filings/filings?ticker=EXEL&form=8-K, /gw/filings/facts?ticker=EXEL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange